Schedule 13G ownership disclosure
ENSYSCE BIOSCIENCES INC
Common Stock, $0.0001 par value · CUSIP: 293602405
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Anson Funds Management LP
Shares: 411,681 · Class: 2.1%
- Anson Management GP LLC
Shares: 411,681 · Class: 2.1%
- Tony Moore
Shares: 411,681 · Class: 2.1%
- Anson Advisors Inc.
Shares: 411,681 · Class: 2.1%
- Amin Nathoo
Shares: 411,681 · Class: 2.1%
- Moez Kassam
Shares: 411,681 · Class: 2.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-021479
- Form type
- SCHEDULE 13G/A
- Filer
- Anson Funds Management LP
- CIK
- CIK 1491072
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership